// App-Quantinova.ai

: Profiling T Cell Receptor Repertoires in Phase I/II Clinical Trials of Donor Treg Infusion for the Treatment of Chronic Graft-Versus-Host Disease

Researchers

Presenter

  • Hans-Jrg Warnatz

Principal Investigators

  • Maria G.D Soares

  • Ana C Alho

  • Laura C Ward

  • Ana C Ribeiro

  • Clara Juncal

  • Anabela Rodrigues

  • Ana Garao

  • Susana Roncon

  • Carlos Pinho Vaz

  • Christine Voigt

  • Marie-Laure Yaspo

  • Hans Lehrach

  • Matthias Edinger

  • Frdric Baron

  • Mario Arpinati

  • Marta Garcia-Fiana

  • Jerome Ritz

  • Joao F Lacerda

Medical Centers

  • Max Planck Institute for Molecular Genetics, Berlin, Germany.

  • Instituto de Medicina Molecular, Faculdade de Medicina Da Universidade de Lisboa, Rheumatology Research Unit, Lisbon, Portugal

  • Hospital de Santa Maria, Lisbon, Portugal

  • Instituto Portugues de Oncologia de Lisboa Francisco Gentil, Lisboa, Portugal

  • Alacris Theranostics GmbH, Berlin, Germany

  • Internal Medicine III, University Hospital, Regensburg, Regensburg, Germany

  • Laboratory of Hematology, University of Liege, Liege, Belgium

  • Institute of Hematology Sera gnoli- St-Orsola-Malpighi Hospital - University of Bologna, Bologna, Italy

  • Department of Biostatistics, Faculty of Health & Life Sciences, University of Liverpool, Liverpool, United Kingdom

  • Department of Medical Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Locations

  • Germany

  • Portugal

  • Belgium

  • Italy

  • United Kingdom

  • United States

Companies

  • Alacris Theranostics

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Graft-versus-host disease

Biomarkers

  • Cluster of Differentiation 4

  • Cluster of differentiation 8A

  • Regulatory T cells

  • T-cell receptor

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • I/II

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved